Timonium, MD, United States of America

Mahendra Rao

This inventor holds 13 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignees: Rxcell Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, Amedica Corporation. Active years: 2004-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahendra Rao. Retrieved from https://idiyas.com/inventor/mahendra-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 281(Granted Patents)


Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Mahendra Rao: Innovator in Stem Cell Research

Introduction

Mahendra Rao is a prominent inventor based in Timonium, MD, known for his significant contributions to the field of stem cell research. With a total of 13 patents to his name, he has made remarkable advancements in the generation and application of induced pluripotent stem cells (iPSCs). His work has the potential to revolutionize therapies and drug screenings in regenerative medicine.

Latest Patents

Among his latest patents, Rao has developed methods and compositions for the rapid generation of single and multiplexed reporters in cells. This innovation includes techniques for the rapid development of reporter lines utilizing safe harbor sites in iPSCs, as well as other progenitor cells, pluripotent and multipotent stem cells, and differentiated cells. Another notable patent involves human iPSC-derived vascular-related and hematopoietic cells for therapies and toxicology/drug screenings. This patent describes cells, cell culture methods, and media compositions that produce and maintain iPSC-derived cell lines with higher purity and better cell type integrity than current options. The described cells include iPSC-derived mesodermal precursor cells (MPC), which can differentiate into various cell types, including hematopoietic stem cells, mesenchymal stem cells, smooth muscle cells, and unlimited functional endothelial cells. These cells can be maintained in culture for extended periods without changing phenotype through differentiation.

Career Highlights

Rao has had a distinguished career, working with notable organizations such as the Government of the United States of America, represented by the Secretary of the Department of Health and Human Services, and Rxcell Inc. His innovative research has garnered attention and respect within the scientific community.

Collaborations

Throughout his career, Rao has collaborated with esteemed colleagues, including Xianmin Zeng and Manfred Boehm. These partnerships have contributed to the advancement of his research and the development of groundbreaking technologies in stem cell applications.

Conclusion

Mahendra Rao's contributions to stem cell research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in regenerative medicine and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…